Link Between the Sensitivity of Kisspeptin Signalling and Pubertal Onset in Boys.
NCT03286517 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2017-09-18
Summary
The specific objective of this study was to investigate the sensitivity of Kisspeptin receptor 1 (KISS1R) by determining the responsiveness of GnRH neuron to kisspeptin administration across the pubertal stages and adult group through measuring plasma LH (luteinizing hormone) and testosterone concentrations.
Conditions
- Reproductive Physiological Phenomena
Interventions
- BIOLOGICAL
-
Kisspeptin-10 (metastin 45-54, Calbiochem, Darmstadt, Germany)
A neurohormone
Sponsors & Collaborators
-
Ghulam Nabi
lead OTHER
Principal Investigators
-
Muhammad Shahab, PhD · Quaid-i-Azam University
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-06-26
- Primary Completion
- 2014-08-08
- Completion
- 2015-03-05
Countries
- Pakistan
Study Locations
More Related Trials
-
Administration of Kisspeptin in Patients With Hyperprolactinemia
NCT02956447 ·Status: COMPLETED ·Phase: PHASE2
-
To Evaluate Recombinant Human Follicle Stimulating Hormone-CTP Fusion Protein Injection or Placebo Combined With Chorionic Gonadotropin for Injection
NCT06561594 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS)
NCT00392756 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Some Puberty-related Hormones Among Children and Adolescents With Chronic Kidney Diseases
NCT05835089 ·Status: UNKNOWN
-
A Clinical Trail to Compare Pharmacokinetics of Two PEG-rhGH Injections With Different Preparations
NCT06135168 ·Status: COMPLETED ·Phase: PHASE1
-
National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Patients
NCT00097513 ·Status: COMPLETED
-
Effect of Exogenous Growth Hormone on Ocular Findings
NCT05338411 ·Status: UNKNOWN
-
Efficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate in Subjects With Central Precocious Puberty
NCT05493709 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism
NCT00493961 ·Status: COMPLETED ·Phase: PHASE1
-
Sexually Dimorphic Effects of GHRH in Adult Growth Hormone Testing
NCT00324064 ·Status: COMPLETED ·Phase: NA
-
Analysis of Genetic and Environmental Parameters Influencing Growth Rate of Precocious Puberty Children
NCT00438217 ·Status: UNKNOWN ·Phase: PHASE4
-
Insulin Sensitivity and Substrate Metabolism Before and After Treatment in Patients With Growth Hormone Deficiency
NCT00646815 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Efficacy and Safety of the Triptorelin 6-month Formulation in Paediatric Participants With Central Precocious Puberty.
NCT05029622 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone Deficiency
NCT01563926 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Pulsatile GnRH Therapy on Male Patients With Pituitary Stalk Interruption Syndrome
NCT02705014 ·Status: UNKNOWN ·Phase: NA
-
A Clinical Trial to Compare Pharmacokinetics of Two Different PEG-rhGH Preparations
NCT06135155 ·Status: COMPLETED ·Phase: PHASE1
-
Validation of a Questionnaire That Identifies the Reasons for Non-adherence to Existing Growth Hormone Therapy
NCT03672617 ·Status: COMPLETED
-
Human Menopausal Gonadotropin Combining With Human Chorionic Gonadotropin Treat Congenital Hypogonadotropic Hypogonadism
NCT02880280 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety Study of Triptorelin 3-Month Formulation in Chinese Children With Central Precocious Puberty.
NCT04736602 ·Status: COMPLETED ·Phase: PHASE3
-
Growth Hormone to Improve the Clinical Outcome of Assisted Fertility in Young Patients With Decreased Ovarian Reserve
NCT05585177 ·Status: RECRUITING ·Phase: NA
-
Substrate Metabolism, Growth Hormone Signaling (GH), and Insulin Sensitivity During GH and Ketone Bodies Infusion
NCT02655263 ·Status: COMPLETED ·Phase: NA
-
Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)
NCT03972345 ·Status: ENROLLING_BY_INVITATION
-
A Study (Phase 1b/2) of GS3-007a Oral Treatment in Children With Growth Hormone Deficiency (PGHD)
NCT07264595 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Long-Term Treatment With rhIGF-1 in GHIS
NCT00571727 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Liquid Somatropin Formulation in Children With Growth Hormone Deficiency
NCT00567385 ·Status: COMPLETED ·Phase: PHASE4